Shares of MedEquities Realty Trust Inc. (NYSE:MRT) have received an average rating of “Buy” from the eight analysts that are currently covering the firm, MarketBeat.com reports. One analyst has rated the stock with a sell rating, two have issued a hold rating and five have assigned a buy rating to the company. The average twelve-month price target among analysts that have covered the stock in the last year is $12.80.

Several equities analysts recently commented on the company. KeyCorp set a $13.00 target price on MedEquities Realty Trust and gave the company a “buy” rating in a research note on Sunday, October 29th. B. Riley reiterated a “buy” rating on shares of MedEquities Realty Trust in a research note on Wednesday, November 1st. Capital One Financial assumed coverage on MedEquities Realty Trust in a research note on Monday, October 23rd. They issued an “equal weight” rating and a $13.00 target price for the company. Zacks Investment Research upgraded MedEquities Realty Trust from a “sell” rating to a “hold” rating and set a $12.00 target price for the company in a research note on Wednesday, November 15th. Finally, ValuEngine upgraded MedEquities Realty Trust from a “hold” rating to a “buy” rating in a research note on Friday, December 1st.

MedEquities Realty Trust (NYSE:MRT) traded up $0.06 during midday trading on Monday, hitting $10.97. The stock had a trading volume of 196,331 shares, compared to its average volume of 153,775. MedEquities Realty Trust has a 12 month low of $10.06 and a 12 month high of $13.06. The firm has a market capitalization of $346.46, a PE ratio of 9.92 and a beta of -0.75.

The firm also recently announced a quarterly dividend, which was paid on Wednesday, November 29th. Investors of record on Wednesday, November 15th were paid a $0.21 dividend. The ex-dividend date of this dividend was Tuesday, November 14th. This represents a $0.84 annualized dividend and a yield of 7.66%. MedEquities Realty Trust’s payout ratio is currently 210.01%.

In other news, CEO John W. Mcroberts purchased 18,000 shares of the company’s stock in a transaction on Friday, November 17th. The stock was bought at an average cost of $10.74 per share, for a total transaction of $193,320.00. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Randy L. Churchey purchased 5,300 shares of the company’s stock in a transaction on Monday, November 20th. The shares were purchased at an average price of $10.87 per share, with a total value of $57,611.00. Following the completion of the purchase, the director now directly owns 46,776 shares of the company’s stock, valued at $508,455.12. The disclosure for this purchase can be found here. Insiders purchased 23,600 shares of company stock valued at $254,129 over the last quarter. Insiders own 2.50% of the company’s stock.

Large investors have recently made changes to their positions in the business. JPMorgan Chase & Co. acquired a new stake in MedEquities Realty Trust during the third quarter worth about $118,000. Raymond James Financial Services Advisors Inc. acquired a new stake in MedEquities Realty Trust during the second quarter worth about $154,000. Acadian Asset Management LLC acquired a new stake in MedEquities Realty Trust during the second quarter worth about $175,000. Alliancebernstein L.P. acquired a new stake in MedEquities Realty Trust during the second quarter worth about $175,000. Finally, Cubist Systematic Strategies LLC acquired a new stake in MedEquities Realty Trust during the third quarter worth about $177,000. Institutional investors own 93.19% of the company’s stock.

TRADEMARK VIOLATION WARNING: This report was posted by American Banking News and is the sole property of of American Banking News. If you are accessing this report on another domain, it was illegally stolen and reposted in violation of United States and international copyright & trademark law. The legal version of this report can be viewed at https://www.americanbankingnews.com/2017/12/11/medequities-realty-trust-inc-mrt-given-consensus-rating-of-buy-by-brokerages.html.

MedEquities Realty Trust Company Profile

MedEquities Realty Trust, Inc is a real estate investment trust (REIT). The Company invests in a diversified mix of healthcare properties and healthcare-related real estate debt investments. The Company invests primarily in real estate across the acute and post-acute spectrum of care. It focuses on investing in various types of healthcare properties, including acute care hospitals; skilled nursing facilities; short-stay surgical and specialty hospitals, which focus on orthopedic, heart and other dedicated surgeries and specialty procedures; dedicated specialty hospitals, such as inpatient rehabilitation facilities, long-term acute care hospitals and facilities providing psychiatric care; physician clinics; diagnostic facilities; outpatient surgery centers, and facilities that support these services, such as medical office buildings.

Analyst Recommendations for MedEquities Realty Trust (NYSE:MRT)

Receive News & Ratings for MedEquities Realty Trust Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MedEquities Realty Trust Inc. and related companies with MarketBeat.com's FREE daily email newsletter.